ES368395A1 - Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos. - Google Patents

Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.

Info

Publication number
ES368395A1
ES368395A1 ES368395A ES368395A ES368395A1 ES 368395 A1 ES368395 A1 ES 368395A1 ES 368395 A ES368395 A ES 368395A ES 368395 A ES368395 A ES 368395A ES 368395 A1 ES368395 A1 ES 368395A1
Authority
ES
Spain
Prior art keywords
active
propanolamine derivatives
active ingredients
sympathicomimetics
adrenolytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES368395A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES368395A1 publication Critical patent/ES368395A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES368395A 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos. Expired ES368395A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1967B0093025 DE1593782B2 (de) 1967-06-15 1967-06-15 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
ES368395A1 true ES368395A1 (es) 1971-05-01

Family

ID=6986720

Family Applications (6)

Application Number Title Priority Date Filing Date
ES354823A Expired ES354823A1 (es) 1967-06-15 1968-06-08 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi-3-ter-butilamino propanos sustituidos.
ES69368396A Expired ES368396A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
ES368398A Expired ES368398A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
ES368401A Expired ES368401A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
ES368399A Expired ES368399A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilamino propanos sustituidos.
ES368395A Expired ES368395A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.

Family Applications Before (5)

Application Number Title Priority Date Filing Date
ES354823A Expired ES354823A1 (es) 1967-06-15 1968-06-08 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi-3-ter-butilamino propanos sustituidos.
ES69368396A Expired ES368396A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
ES368398A Expired ES368398A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
ES368401A Expired ES368401A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
ES368399A Expired ES368399A1 (es) 1967-06-15 1969-06-16 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilamino propanos sustituidos.

Country Status (17)

Country Link
JP (2) JPS51100B1 (es)
AT (8) AT289077B (es)
BE (1) BE716647A (es)
BG (6) BG15039A3 (es)
CH (1) CH495950A (es)
DE (1) DE1593782B2 (es)
DK (1) DK127059B (es)
ES (6) ES354823A1 (es)
FI (1) FI48922C (es)
FR (2) FR1583559A (es)
GB (1) GB1187546A (es)
IE (1) IE32373B1 (es)
IL (1) IL30181A (es)
MY (1) MY7300288A (es)
NL (2) NL6808196A (es)
SE (1) SE355571B (es)
YU (7) YU33780B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937834A (en) 1970-10-02 1976-02-10 Ciba-Geigy Corporation Pharmaceutical preparations
JPS57125772U (es) * 1981-01-30 1982-08-05
DE3744371A1 (de) * 1987-12-29 1989-07-13 Jacobs Suchard Ag Verpackung fuer suesswaren
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (es) * 1962-12-11

Also Published As

Publication number Publication date
FI48922B (es) 1974-10-31
IL30181A0 (en) 1968-08-22
ES368396A1 (es) 1971-05-01
ES368398A1 (es) 1971-05-01
JPS5112613B1 (es) 1976-04-21
AT289079B (de) 1971-04-13
IE32373L (en) 1968-12-15
AT289082B (de) 1971-04-13
BG15038A3 (bg) 1975-06-10
NL136601C (es)
YU33778B (en) 1978-05-15
YU33779B (en) 1978-05-15
DE1593782A1 (de) 1972-04-20
DE1593782B2 (de) 1976-09-09
YU229074A (en) 1977-10-31
MY7300288A (en) 1973-12-31
YU33775B (en) 1978-05-15
NL6808196A (es) 1968-12-16
IE32373B1 (en) 1973-07-11
IL30181A (en) 1972-01-27
JPS51100B1 (es) 1976-01-05
YU35578B (en) 1981-04-30
BG15039A3 (bg) 1975-12-15
YU33780B (en) 1978-05-15
AT289081B (de) 1971-04-13
AT289076B (de) 1971-04-13
BG15037A3 (bg) 1975-12-12
BG15041A3 (bg) 1975-10-22
SE355571B (es) 1973-04-30
BG15040A3 (bg) 1975-10-25
BE716647A (es) 1968-12-16
FI48922C (fi) 1975-02-10
FR8162M (es) 1970-08-24
YU228974A (en) 1977-10-31
YU228874A (en) 1977-10-31
CH495950A (de) 1970-09-15
YU33776B (en) 1978-05-15
FR1583559A (es) 1969-11-14
AT289077B (de) 1971-04-13
YU33777B (en) 1978-05-15
YU229474A (en) 1977-10-31
ES368399A1 (es) 1971-05-01
AT289080B (de) 1971-04-13
GB1187546A (en) 1970-04-08
YU229374A (en) 1980-09-25
BG15042A3 (bg) 1975-10-20
ES354823A1 (es) 1970-02-16
AT289067B (de) 1971-04-13
YU229174A (en) 1977-10-31
YU229274A (en) 1977-10-31
DK127059B (da) 1973-09-17
ES368401A1 (es) 1971-05-01
AT289078B (de) 1971-04-13

Similar Documents

Publication Publication Date Title
ES379739A1 (es) Procedimiento para la preparacion de preparados farmaceuti-cos que contienen en calidad de sustancia activa nuevos 1-fenoxi-2-hidroxi-3-sec - alcohilaminopropanos racemicos u opticamente activos.
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ES438931A1 (es) Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano.
ES385523A1 (es) Procedimiento para la preparacion de compuestos farmacolo- gicamente activos de esteres de acido antranilico.
ES368396A1 (es) Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
GB1362845A (en) Benzyl alcohol derivatives
BE622943A (fr) Compositions thérapeutiques, contenant des dérivés d'émétine.
ES365335A1 (es) Procedimiento para preparar amimocetonas aromaticas.
GB1261989A (en) 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same
SE7508516L (sv) Sett att framstella ny alkaloid av eburnamintypen
ES372009A1 (es) Mejoras introducidas en un procedimiento para la prepara- cion de una combinacion de drogas capaz de aumentar el con- tenido en dopamina del tejido cerebral.
ES346192A1 (es) Un metodo de preparacion del compuesto quimico acido 6-clo-ro-2-(5-nitro-2 furil) cinconinico.
GB1287433A (en) Pharmaceutical compositions
ES378186A1 (es) Un metodo de producir un compuesto de azamorfinano.
GB1175590A (en) Therapeutic Compositions
ES346424A1 (es) Un procedimiento para la preparacion de compuestos sedan- tes.
ES363792A1 (es) Procedimiento para la elaboracion de bisulfanilamina triha-logenopiridinas.
GB1262140A (en) Pharmaceutical compositions
GB1276942A (en) Derivatives of chloramphenicol and thiamphenicol
GB1134516A (en) Antiviral compositions and treatment
SE326175B (es)
ES340846A1 (es) Procedimiento de preparacion del compuesto 3,5,3'-triiodo- tiroacetato de reserpina.
GB1159174A (en) Pharmaceutical Compositions
GB1183455A (en) 2,3,4,5,6 - Pentachlorobenzylidenamine Derivatives
ES343446A1 (es) Procedimiento para preparar 1-(3,5-dimetoxi-4-hidroxifenil)-2 - monometilaminoetanol.